randomized, blinded, sham-controlled trial. Support Care
74. Finnegan-John J, Molassiotis A, Richardson A, Ream E. A
systematic review of complementary and alternative medicine interventions for the management of cancer-related
fatigue. Integr Cancer Ther 2013;12:276–90.
75. Schwartz AL, Thompson JA, Masood N. Interferon-induced
fatigue in patients with melanoma: a pilot study of exercise
and methylphenidate. Oncol Nurs Forum 2002;29:E85–90.
76. Spathis A, Dhillan R, Booden D, et al. Modafinil for the
treatment of fatigue in lung cancer: a pilot study. Palliat
77. Blackhall L, Petroni G, Shu J, et al. A pilot study evaluating the safety and efficacy of modafinal for cancer-related
fatigue. J Palliat Med 2009;12:433–9.
78. Qu D, Zhang Z, Yu X, et al. Psychotropic drugs for the
management of cancer-related fatigue: a systematic review
and meta-analysis. Eur J Cancer Care (Engl) 2015;25:970– 9.
79. Minton O, Richardson A, Sharpe M, et al. Drug therapy
for the management of cancer-related fatigue. Cochrane
Database Syst Rev 2010( 7):CD006704.
80. Moraska AR, Sood A, Dakhil SR, et al. Phase III, randomized, double-blind, placebo-controlled study of long-acting
methylphenidate for cancer-related fatigue: North Central
Cancer Treatment Group NCCTG-N05C7 trial. J Clin
81. Bruera E, Driver L, Barnes EA, et al. Patient-controlled
methylphenidate for the management of fatigue in patients
with advanced cancer: a preliminary report. J Clin Oncol
82. Kerr CW, Drake J, Milch RA, et al. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage
83. Escalante CP, Meyers C, Reuben JM, et al. A randomized,
double-blind, 2-period, placebo-controlled crossover trial
of a sustained-release methylphenidate in the treatment of
fatigue in cancer patients. Cancer J 2014;20: 8–14.
84. Mar Fan HG, Clemons M, Xu W, et al. A randomised,
placebo-controlled, double-blind trial of the effects of
d-methylphenidate on fatigue and cognitive dysfunction
in women undergoing adjuvant chemotherapy for breast
cancer. Support Care Cancer 2008;16:577–83.
85. Butler JM Jr, Case LD, Atkins J, et al. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor
patients receiving radiation therapy. Int J Radiat Oncol Biol
86. Hovey E, de Souza P, Marx G, et al. Phase III, randomized,
double-blind, placebo-controlled study of modafinil for
fatigue in patients treated with docetaxel-based chemotherapy. Support Care Cancer 2014;22:1233–42.
87. Spathis A, Fife K, Blackhall F, et al. Modafinil for the
treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol
88. Berenson JR, Yellin O, Shamasunder HK, et al. A phase
3 trial of armodafinil for the treatment of cancer-related
fatigue for patients with multiple myeloma. Support Care
Cancer 2015; 23:1503–12.
89. Boele FW, Douw L, de Groot M, et al. The effect of
modafinil on fatigue, cognitive functioning, and mood in
primary brain tumor patients: a multicenter randomized
controlled trial. Neuro Oncol 2013;15:1420–8.
90. Jean-Pierre P, Morrow GR, Roscoe JA, et al. A phase 3 r
andomized, placebo-controlled, double-blind, clinical
trial of the effect of modafinil on cancer-related fatigue
among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical
Oncology Program Research base study. Cancer 2010;116:
91. Conley CC, Kamen CS, Heckler CE, et al. Modafinil moderates the relationship between cancer-related fatigue and
depression in 541 patients receiving chemotherapy. J Clin
92. Brattsand R, Linden M. Cytokine modulation by glucocor-ticoids: mechanisms and actions in cellular studies. Aliment
Pharmacol Ther 1996; 10 Suppl 2:81–90.
93. Yennurajalingam S, Frisbee-Hume S, Palmer JL, et al.
Reduction of cancer-related fatigue with dexamethasone:
a double-blind, randomized, placebo-controlled trial in
patients with advanced cancer. J Clin Oncol 2013;31:
94. Bruera E, Roca E, Cedaro L, et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep
95. Pulivarthi K, Dev R, Garcia J, et al. Testosterone replacement for fatigue in male hypogonadic patients with
advanced cancer: A preliminary double-blind placebo-controlled trial. J Clin Oncol 2012; 30 (suppl). Abstract
96. Palesh OG, Mustian KM, Peppone LJ, et al. Impact of paroxetine on sleep problems in 426 cancer patients receiving
chemotherapy: a trial from the University of Rochester
Cancer Center Community Clinical Oncology Program.
Sleep Med 2012;13:1184–90.
97. Thekdi SM, Trinidad A, Roth A. Psychopharmacology in
Cancer. Curr Psychiatry Rep 2014;17:529.
98. Lesser GJ. Case D, Stark N, et al. A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to
relieve self-reported treatment-related fatigue in newly
diagnosed patients with breast cancer. J Support Oncol
99. Barton DL, Liu H, Dakhil SR, et al. Wisconsin Ginseng
(Panax quinquefolius) to improve cancer-related fatigue: a
randomized, double-blind trial, N07C2. J Natl Cancer Inst
100. Yennurajalingam S, Reddy A, Tannir NM, et al. High-dose Asian ginseng (panax ginseng) for cancer-related
fatigue: a preliminary report. Integr Cancer Ther 2015;14:
101. Howell D, Keller-Olaman S, Oliver TK, et al. A pan-Cana-dian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related
fatigue. Curr Oncol 2013;20:e233–46.